Search results
Results From The WOW.Com Content Network
Another problem popped up in 2013, one that could have closed 23andMe for good. The Food and Drug Administration decided that 23andMe’s test and health reports about a person’s predisposition ...
DNA-testing service 23andMe is making substantial efforts to nurse its feeble genetic core back to health. The company will lay off 40% of its workforce, over 200 employees, and cull its therapy ...
23andMe went public in June 2021, a few months before the Lemonaid deal closed, at $11.13 a share. Since then, 23andMe's stock price has tumbled, partly because of a massive data breach and a ...
23andMe continued to evolve its services, and in 2015, the FDA granted authorization to market its screening for Bloom syndrome, a rare genetic disorder, the company said at the time.
That the company has sold test kits to 15 million customers, was once worth more than $6 billion, and become a giant in genomics is “all down to Anne and her determination,” one person said.
Genetic testing firm 23andMe said on Monday it is reducing about 40%, or 200 employees, from its workforce and discontinuing further development of all its therapies as part of a restructuring ...
The breach began around April 2023 and lasted about five months, affecting nearly half of the 14.1 million customers in 23andMe's database at the time. It was disclosed by 23andMe in an October ...
One measure of inflation, the consumer price index, shows the food index was flat in April compared to the prior month. Yet over the past 12 months, food was up 2.2% .